As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

Women prescribed a GLP-1 receptor agonist up to 2 years before conception were less likely to develop hypertensive disorders ...

Medicenna's financial statements for the three and nine months ended December 31, 2024, and the related management's discussion and analysis (MD&A) will be available on SEDAR+ at sedarplus.ca.

The data, published in JAMA Psychiatry, add to the growing body of evidence supporting the use of GLP-1 receptor agonists for ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.

Evan Y. Yu, MD, discusses other ongoing investigations exploring combinations based on radium-223 (Ra-223), highlighting ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

A kindhearted nine-year-old Chesterfield swimmer is taking on a 20km swim along with 16 other youngsters, raising money for ...